| Revenue | 365,906.35a | 270,970.14a |
| Cost of sales | -289,346.16a | -213,493.9a |
| Gross profit | 76,560.19a | 57,476.24a |
| Research and development expenses | -24,050.48a | -19,097.7a |
| Selling and marketing expenses | -25,389.63a | -19,226.54a |
| Administrative expenses | -5,601.25a | -5,126.8a |
| Fair value changes on financial instruments measured at fair value through profit or loss | 1,050.77a | 3,501.05a |
| Share of net profits of investments accounted for using the equity method | 276.85a | 45.62a |
| Other income | 1,666.78a | 740.09a |
| Other (losses)/gains, net | -10.33a | 1,696.71a |
| Operating profit | 24,502.9a | 20,008.67a |
| Finance income | 3,836.2a | 3,558.35a |
| Finance costs | -212.45a | -1,555.97a |
| Profit before income tax | 28,126.65a | 22,011.05a |
| Income tax expenses | -4,548.2a | -4,536.85a |
| Profit for the year | 23,578.45a | 17,474.2a |
| Attributable to: | — | — |
| Owners of the Company | 23,658.13a | 17,475.17a |
| Non-controlling interests | -79.68a | -0.98a |